Point-of-care diagnostics company Alere Inc. has acquired private drugs-of-abuse screening firm eScreen Inc. for $270mm in cash up front, plus another $70mm in earn-outs. (Feb.)
EScreen, which reported 2011 revenues of $120mm, was formed in 1998 to provide drugs-of-abuse screening and automated hiring services. In...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on In Vivo for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?